Trade Summary

10 months ago, Lenk Robert P, serving as Dir at Plus Therapeutics, Inc. (PSTV), purchased 110,000 shares at $0.49 per share, for a total transaction value of $53,779.00. Following this transaction, Lenk Robert P now holds 139,327 shares of PSTV.

This purchase represents a 375.00% increase in Lenk Robert P's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, August 22, 2025 and publicly disclosed via SEC Form 4 filing on Monday, August 25, 2025 at 3:30 AM ET, 3 days after the trade was made.

Plus Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.